Global Cord Blood
CORBF
#9315
Rank
NZ$0.25 B
Marketcap
NZ$1.92
Share price
0.00%
Change (1 day)
43.11%
Change (1 year)
Categories

Earnings for Global Cord Blood (CORBF)

Earnings in 2022 (TTM): NZ$0.13 Billion

According to Global Cord Blood's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2021 the company made an earning of NZ$0.17 Billion, an increase over its 2020 earnings that were of NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Global Cord Blood from 2008 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) NZ$0.13 B-21.05%
2021 NZ$0.17 B15.78%
2020 NZ$0.15 B10.11%
2019 NZ$0.13 B46.83%
2018 NZ$93.03 M5.31%
2017 NZ$88.33 M22.57%
2016 NZ$72.07 M-3.68%
2015 NZ$74.82 M-6.8%
2014 NZ$80.28 M8.79%
2013 NZ$73.8 M19.85%
2012 NZ$61.57 M39.37%
2011 NZ$44.18 M34.18%
2010 NZ$32.92 M124.91%
2009 NZ$14.63 M-563.02%
2008 -NZ$3.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
RadNet
RDNT
NZ$0.19 B 11.79%๐Ÿ‡บ๐Ÿ‡ธ USA
National Healthcare
NHC
NZ$0.34 B 97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$60.21 Million-134.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Cryo-Cell International
CCEL
-NZ$2.24 Million-101.28%๐Ÿ‡บ๐Ÿ‡ธ USA